Artwork

Content provided by ResearchPod. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ResearchPod or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Personalised genetic insights: A revolution in papillary thyroid cancer

9:54
 
Share
 

Manage episode 455771421 series 2680968
Content provided by ResearchPod. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ResearchPod or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

While the management of papillary thyroid cancer (PTC) is guided by recurrence risk assessment, current methods cannot accurately predict disease recurrence.
Professor Oliver Bathe and his collaborators at the University of Calgary, Canada, have developed a test that includes genetic data linked to recurrence. Together, they identified three molecular PTC subtypes, allowing more accurate risk assessment to guide clinical decision-making and treatment.

Read more in Research Features
Read the original research: doi.org/10.3389/fendo.2023.1220617

  continue reading

477 episodes

Artwork
iconShare
 
Manage episode 455771421 series 2680968
Content provided by ResearchPod. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ResearchPod or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

While the management of papillary thyroid cancer (PTC) is guided by recurrence risk assessment, current methods cannot accurately predict disease recurrence.
Professor Oliver Bathe and his collaborators at the University of Calgary, Canada, have developed a test that includes genetic data linked to recurrence. Together, they identified three molecular PTC subtypes, allowing more accurate risk assessment to guide clinical decision-making and treatment.

Read more in Research Features
Read the original research: doi.org/10.3389/fendo.2023.1220617

  continue reading

477 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play